“Shares of iTeos Therapeutics Inc. ITOS, 30.79% soared 58.5% in premarket trading on Monday after the company announced a deal with GlaxoSmithKline GSK, +0.39% to develop and commercialize an experimental cancer therapy. GSK will make a $625 million upfront payment to iTeos, with an additional $1.4… Continue Reading…